On September 4th at 10 AM New York time a select group of investors from America, Europe, Asia and the Middle East will gather on a group-video-call. This exclusive session will focus on healthcare innovations with transformative business potential.

After the opening exchange of insights, participants will take part in a deep dive into SurgiBox — an award-winning company enabling safe surgery at any time, in any place. Their flagship product is an ultra-portable, battery-powered solution that creates sterile surgical conditions, equally suited for private clinics and the most hard-to-reach austere settings, including disaster and conflict zones.

The agenda of the gathering:

• An interactive round table where investors discuss overlooked areas in healthcare with high potential impact
• A live presentation of SurgiBox, its technology, traction, and growth strategy
• A co-development session where investors contribute strategic input and explore synergies with the founding team
• A final round of one-to-one meetings between investors and SurgiBox, as well as with each other, enabling direct follow-ups and alignment

SurgiBox was founded by Harvard Medical School-educated clinicians and incubated at MIT D-Lab. It already has signed distributors in multiple countries, generates revenue, and projects growth to $46M by 2029.

The company is raising $7M for 20% equity, aimed at accelerating market entry, expanding manufacturing, and strengthening distribution networks.

Held via video group call on September 4, 2025, the session runs for 3 hours
(6–9 PM Dubai / 10 AM–1 PM New York / 4–7 PM Zurich time).